Drug search by name

Moxetumomab pasudotox and Renal impairment

Result of checking the interaction of drug Moxetumomab pasudotox and disease Renal impairment for safety when used together.

Check result:

Moxetumomab pasudotox <> Renal impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Renal toxicity has been reported in patients treated with moxetumomab pasudotox . Patients have reported renal toxicity, including acute kidney injury, renal failure, serum creatinine increase, and proteinuria. Patients with renal impairment are at increased risk for worsening of renal function during or following treatment. Caution and monitoring is advised if using in patients with renal impairment. The use of moxetumomab pasudotox is not recommended in patients with severe renal impairment (CrCl = 29 mL/min).

Moxetumomab pasudotox

Generic Name: moxetumomab pasudotox

Brand Name: Lumoxiti

Synonyms: Moxetumomab Pasudotox

What is Moxetumomab pasudotox?